Barbarani Gloria, Fugazza Cristina, Strouboulis John, Ronchi Antonella E
Dipartimento di Biotecnologie e Bioscienze, Università degli Studi Milano-Bicocca, Milan, Italy.
School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.
Front Physiol. 2019 Feb 12;10:91. doi: 10.3389/fphys.2019.00091. eCollection 2019.
In the last few years, the advent of new technological approaches has led to a better knowledge of the ontogeny of erythropoiesis during development and of the journey leading from hematopoietic stem cells (HSCs) to mature red blood cells (RBCs). Our view of a well-defined hierarchical model of hematopoiesis with a near-homogeneous HSC population residing at the apex has been progressively challenged in favor of a landscape where HSCs themselves are highly heterogeneous and lineages separate earlier than previously thought. The coordination of these events is orchestrated by transcription factors (TFs) that work in a combinatorial manner to activate and/or repress their target genes. The development of next generation sequencing (NGS) has facilitated the identification of pathological mutations involving TFs underlying hematological defects. The examples of GATA1 and KLF1 presented in this review suggest that in the next few years the number of TF mutations associated with dyserythropoietic disorders will further increase.
在过去几年中,新技术方法的出现使我们对发育过程中红细胞生成的个体发生以及从造血干细胞(HSC)到成熟红细胞(RBC)的过程有了更深入的了解。我们之前认为造血是一个定义明确的分层模型,顶端是几乎同质的HSC群体,这种观点正逐渐受到挑战,取而代之的是一种新观点,即HSC本身高度异质,且谱系分离比之前认为的更早。这些事件的协调由转录因子(TF)精心安排,这些转录因子以组合方式发挥作用,激活和/或抑制其靶基因。新一代测序(NGS)技术的发展促进了对导致血液学缺陷的TF相关病理突变的鉴定。本综述中提到的GATA1和KLF1的例子表明,在未来几年,与红细胞生成异常性疾病相关的TF突变数量将进一步增加。